PBYI

PUMA BIOTECHNOLOGY INC

PBYI·74587V107·US·Common Stock·Healthcare - Biotechnology-13D/G

PBYI (PUMA BIOTECHNOLOGY INC) is held by 90 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($30.9M), AMERICAN CENTURY COMPANIES INC ($18.8M), RENAISSANCE TECHNOLOGIES LLC ($14.9M). Net institutional sentiment: Mixed.

90
Holders
(8 Elite)
$215.9M
Total Value
60% (89)
Consensus
53 buying - 36 selling
13F: Insider & Congress: Updated regularly
PBYI

Smart Money Verdict

View all
Loading verdict
Held by 90 funds
8 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jan 8, 2026 · Activists Mar 27, 2026 · Congress none

ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderAHAUERBACH ALAN HSell $106KJan 7, 2026
InsiderHMHUNT DOUGLAS MSell $29KJan 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.8M(+5.7%)$30.9M0.0%+165.68%
31
Increased
2.3M(+21.1%)$18.8M0.0%+83.12%
34
Decreased
1.8M(-5.5%)$14.9M0.0%+35.33%
0
Increased
1.8M(+1.0%)$14.9M0.0%+47.06%
28
Increased
1.8M(+5.2%)$14.8M0.0%+45.29%
30
Increased
1.5M(+5.7%)$12.3M0.0%+134.34%
30
Increased
1.3M(+31.7%)$10.9M0.0%+36.34%
35
Decreased
1.1M(-1.3%)$9.1M0.0%+94.46%
0
Increased
952,165(+3.8%)$7.7M0.0%+123.39%
28
Decreased
725,192(-9.4%)$5.9M0.0%+63.73%
0
Decreased
669,156(-0.1%)$5.4M0.0%+74.88%
0
Increased
652,386(+1.7%)$5.3M0.0%+27.08%
27
Decreased
642,946(-17.9%)$5.2M0.0%+153.35%
0
Increased
636,761(+19.2%)$5.2M0.0%+52.45%
32
Decreased
602,240(-59.2%)$4.9M0.0%+47.67%
0
Decreased
532,450(-1.1%)$4.3M0.0%+150.73%
0
Decreased
418,669(-17.6%)$3.4M0.0%+16.97%
0
Increased
360,734(+3.7%)$2.9M0.0%+102.24%
27
Decreased
316,343(-9.9%)$2.6M0.0%+194.74%
0
Increased
309,106(+13.3%)$2.5M0.0%+42.79%
30

Showing 1-20 of 96

1 / 5
PBYIPBYIPUMA BIOTECHNOLOGY INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used